FCGR1CP and tuberculosis: As shown in Figures 5A–C and Figure S9, compared to LTBI controls, the expressions of FCGR1A, FCGR1B, and FCGR1CP were all increasing when progressors were approaching clinical TB and decreasing when progressors were undergoing chemotherapy.